Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ACOG
Alpha Cognition Inc. Common Stock
Financial Services | Financial - Conglomerates
$6.01+0.02 (+0.33%)as of 2026-07-14 15:14 UTC
Market Cap$130M
Volume25.0K
EPS (TTM)$-1.18
Alpha Cognition Inc. Common Stock (NASDAQ: ACOG) is a $130M financial - conglomerates company trading at $6.01 (+0.3% today). Figures from SEC EDGAR and market feeds; updated 2026-07-14 15:14 UTC.
52-Week Range
Low $4.50High $11.54
What Alpha Cognition Inc. Common Stock does
The company is a biopharmaceutical firm focused on treating neurodegenerative diseases, particularly Alzheimer's disease. Its lead product, ZUNVEYL, is an oral tablet formulation that received FDA approval and launched commercially in March 2025, targeting long-term care facilities through a specialized sales team. ZUNVEYL is positioned as a next-generation acetylcholinesterase inhibitor with a mechanism that differs from existing treatments by binding to neuronal nicotinic receptors.
Summarized from Alpha Cognition Inc. Common Stock’s SEC filings · Read the filing ↗
The company is a biopharmaceutical firm focused on treating neurodegenerative diseases, particularly Alzheimer's disease.
What is ACOG's valuation?
ACOG trades at $6.01, as of 2026-07-14.
When did ACOG last file with the SEC?
Alpha Cognition Inc. Common Stock's most recent SEC filing on record is a 8-K filed 2026-06-23. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-14 15:14 UTC. This page is also available as JSON at /api/data?ticker=ACOG and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACOG and 3,500+ tickers.
